Dealflicks endeavors to put movie fans in cheaper seats
On a quiet residential street in Mid-Wilshire, Kevin Hong and his sales team huddled around a parked Toyota Sienna emblazoned with a magnet sticker reading “Dealflicks Coupon Code: Man Van.”
They were loading the converted minivan with suitcases, sleeping bags, brochures and yellow “Dealflicks” T-shirts in preparation for a six-week road trip to visit movie theaters in Kansas, Iowa, Michigan, Boston and Illinois. The sales team members planned to take turns sleeping and driving as they stopped by theaters to personally market their service.
After four road trips and logging more than 40,000 miles to dozens of cities, Hong and his team have helped transform Dealflicks Inc. from a fledgling Los Angeles startup into a fast-growing discount ticketing service for theaters across the country.
“The idea is to increase as much face time as possible,” said Hong, co-founder of Dealflicks. “We'll be hitting as many theaters as we can.”
Billed as a Priceline or Hotwire for movie tickets, Dealflicks partners with theaters to offer discounts of as much as 60 percent on movie tickets and concessions when theaters are mostly vacant.
That's an appealing pitch when average movie ticket prices reached record levels in 2013 and theaters are experimenting with ways to bring in customers to the multiplex. Last year, theaters in the United States and Canada drew 1.34 billion patrons, down from 1.5 billion nearly a decade ago, according to a recent report by the Motion Picture Association of America.
“Right now, 88 percent of movie theaters are empty,” said Sean Wycliffe, chief executive of Dealflicks. “We'll say, ‘Give us some of your excess inventory ... and we'll do all the marketing for you.' ”
Dealflicks lets theater owners select which movies they wish to discount, at what price and when. Customers buy the tickets through Dealflicks' website or iPhone app.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
- Wolf reverses Corbett, says deal between Highmark, UPMC doesn’t limit continuity of care to very ill
- Alcoa may close or sell some aluminum plants to cut costs
- Apple to replace AT&T in Dow
- Unemployment rate continues to drop as U.S. adds 295K jobs
- Big banks’ levels of capital strong, Federal Reserve finds
- AbbVie to buy leukemia drugmaker Pharmacyclics for $21 billion
- Worker productivity falls faster than estimated; labor costs rise
- Race toward bigger phones eases
- Americans see improved job market but a vulnerable economy, Pew poll finds
- IPO might test Etsy’s approach to commerce
- Researchers: U.S. lacks proving ground for nuclear energy innovations